Literature DB >> 26547310

Author's Reply to Standing et al. Pharmacokinetic Studies in Neonates: The Utility of an Opportunistic Sampling Design.

Wei Zhao1,2,3,4, Evelyne Jacqz-Aigrain5,6.   

Abstract

Mesh:

Year:  2015        PMID: 26547310     DOI: 10.1007/s40262-015-0341-8

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  4 in total

1.  Pharmacokinetic Studies in Neonates: The Utility of an Opportunistic Sampling Design.

Authors:  Stéphanie Leroux; Mark A Turner; Chantal Barin-Le Guellec; Helen Hill; Johannes N van den Anker; Gregory L Kearns; Evelyne Jacqz-Aigrain; Wei Zhao
Journal:  Clin Pharmacokinet       Date:  2015-12       Impact factor: 6.447

2.  Shape does matter: short high-concentration exposure minimizes resistance emergence for fluoroquinolones in Pseudomonas aeruginosa.

Authors:  Vanessa E Rees; Jürgen B Bulitta; Roger L Nation; Brian T Tsuji; Fritz Sörgel; Cornelia B Landersdorfer
Journal:  J Antimicrob Chemother       Date:  2014-11-06       Impact factor: 5.790

3.  Comment on Pharmacokinetic Studies in Neonates: The Utility of an Opportunistic Sampling Design.

Authors:  Joseph F Standing; Brian J Anderson; Nicholas H G Holford; Irja Lutsar; Tuuli Metsvaht
Journal:  Clin Pharmacokinet       Date:  2015-12       Impact factor: 6.447

4.  Population pharmacokinetics of metronidazole evaluated using scavenged samples from preterm infants.

Authors:  Michael Cohen-Wolkowiez; Daniele Ouellet; P Brian Smith; Laura P James; Ashley Ross; Janice E Sullivan; Michele C Walsh; Arlene Zadell; Nancy Newman; Nicole R White; Angela D M Kashuba; Daniel K Benjamin
Journal:  Antimicrob Agents Chemother       Date:  2012-01-17       Impact factor: 5.191

  4 in total
  1 in total

1.  Population Pharmacokinetic Study of Cefathiamidine in Infants With Augmented Renal Clearance.

Authors:  Bin Du; Yue Zhou; Bo-Hao Tang; Yue-E Wu; Xin-Mei Yang; Hai-Yan Shi; Bu-Fan Yao; Guo-Xiang Hao; Dian-Ping You; John van den Anker; Yi Zheng; Wei Zhao
Journal:  Front Pharmacol       Date:  2021-03-15       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.